Madrigal Pharmaceuticals | 4:持股变动声明-高管 Waltermire Robert E.
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Waltermire Robert E.
Madrigal Pharmaceuticals | 4:持股变动声明-董事 CRAVES FRED B
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Waltermire Robert E.
Madrigal Pharmaceuticals | 4:持股变动声明-董事 CRAVES FRED B
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Taub Rebecca
Madrigal Pharmaceuticals | 4:持股变动声明-董事 FRIEDMAN PAUL A
Madrigal Pharmaceuticals | 4:持股变动声明-高管 Taub Rebecca
Madrigal Pharmaceuticals | 4:持股变动声明-董事 FRIEDMAN PAUL A
Madrigal Pharmaceuticals | 4:持股变动声明-董事 Levy Richard S
Madrigal Pharmaceuticals | 4:持股变动声明-董事 BATE KENNETH
Madrigal Pharmaceuticals | 4:持股变动声明-董事 Daly James M
Madrigal Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%)等
Madrigal Pharmaceuticals | 4:持股变动声明-董事 BAKER BROS. ADVISORS LP
Madrigal Pharmaceuticals | 3:首次持股声明-高管 Dier Mardi
Madrigal Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-PAULSON & CO. INC.(5.6%)
Madrigal Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Armistice Capital, LLC(0.25%),Steven Boyd(0.25%)
Madrigal Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(9.9%),Behzad Aghazadeh(9.9%)
Madrigal Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.98%)
Madrigal Pharmaceuticals | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(14.7%)
暂无数据